SITC Cancer Immunotherapy CONNECT

Learn more about the new SITC Biotech Initiative

Browse our other events


SITC Drug Development Summit

SITC Immuno-oncology Drug Development Summit

Sept. 30 – Oct. 1, 2024 in Boston at The Revere Hotel Boston Common

The SITC Immuno-oncology Drug Development Summit will ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing.

Learn More
Immunotherapy

Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

Explore the 2024 ACI Series
Glyco-Immunology Webinar

2024 Glyco-Immunology Webinar Series

Presented by SITC and the Society for Glycobiology, this FREE webinar series will address the impact of glycobiology on immune regulation, anti-tumor immunity, and immune resistance. Develop more effective cancer immunotherapies by applying principles of glyco-immunology.

EXPLORE SERIES

AI in IO

Computational Immuno-oncology Webinar - Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncology

Live Webinar 4: Tuesday, July 30, 2024 - 1:30–2:30 p.m. EDT

Advance your training in computational immuno-oncology and stay abreast of the latest technologies. Register for FREE!

Register Today

ACI Hematologic

Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies

Wednesday, Sept. 11 |1–5 p.m. ET 
Virtual – Zoom

Program addresses how to identify and manage CAR T -associated secondary malignancies. FREE for healthcare professionals, students, patients and patient advocates.

Register
ACI Toxicity Management

Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Wednesday, Oct. 9 |11 a.m.–3 p.m. ET Virtual – Zoom

Program features a session on emerging therapies, where the EMERALD trial and FLASH radiotherapy plan to be discussed. 

Explore Program
2025 Winter School

2025 Cancer Immunotherapy Winter School

February 11–14, 2025 in Austin, TX
and Virtually

Explore the core principles of tumor immunology and cancer immunotherapy, including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.

Register Today

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events


 Read the Latest SITC News

In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical ...
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical ...

JITC Digest July 2024

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor ...

 Latest Discussions

  • Hello! SITC is pleased to host two Virtual Summits in the upcoming months! ...

  • Hello! Attached is a flyer for the SITC Summit on Intralesional Immunotherapy: ...

  • Hello! Attached is a flyer for the SITC Summit on Immunomodulation ...

    1 person likes this.

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family